1. Home
  2. PLUR

PLUR

Pluri Inc.

Logo Pluri Inc.

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility.

Founded: 2001 Country:
Israel
Israel
Employees: N/A City: HAIFA
Market Cap: 31.2M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 29.3K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -4.64 EPS Growth: N/A
52 Week Low/High: $3.44 - $8.56 Next Earning Date: 05-07-2024
Revenue: $357,000 Revenue Growth: 10.53%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: